Infections caused by drug resistant bacteria poses a significant threat to global human
health, with predicted annual mortality of 10 million by 2050. While much attention is focused
on developing better therapies, improving diagnosis would allow for rapid initiation of
optimal treatment, reducing unnecessary antibiotic use and enhancing therapeutic
outcomes. There are currently no whole body imaging techniques in clinical use that are
capable of specifically identifying bacterial infections. We have developed antibiotic-derived …